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Cigarette smoke (CS) is the major cause of chronic lung injuries, such as chronic
obstructive pulmonary disease (COPD). In patients with severe COPD, tertiary lymphoid
follicles containing B lymphocytes and B cell-activating factor (BAFF) overexpression
are associated with disease severity. In addition, BAFF promotes adaptive immunity in
smokers and mice chronically exposed to CS. However, the role of BAFF in the early
phase of innate immunity has never been investigated. We acutely exposed C57BL/6J
mice to CS and show early BAFF expression in the bronchoalveolar space and lung tissue
that correlates to airway neutrophil and macrophage influx. Immunostaining analysis
revealed that neutrophils are the major source of BAFF. We confirmed in vitro that
neutrophils secrete BAFF in response to cigarette smoke extract (CSE) stimulation.
Antibody-mediated neutrophil depletion significantly dampens lung inflammation to CS
exposure but only partially decreases BAFF expression in lung tissue and bronchoalveolar
space suggesting additional sources of BAFF. Importantly, BAFF deficient mice displayed
decreased airway neutrophil recruiting chemokines and neutrophil influx while the
addition of exogenous BAFF significantly enhanced this CS-induced neutrophilic
inflammation. This demonstrates that BAFF is a key proinflammatory cytokine and that
innate immune cells in particular neutrophils, are an unconsidered source of BAFF in early
stages of CS-induced innate immunity.
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INTRODUCTION
Inflammatory lung diseases represent a major public health problem. Their incidence is constantly
increasing and the predictions of the World Health Organization (WHO) are at least pessimistic
over the next 20–30 years, reflecting recent changes in our society and the associated consequences
on air quality and social behavior. In particular, chronic obstructive pulmonary disease (COPD)
is characterized by chronic bronchitis and pulmonary emphysema and is triggered by repeated
airway exposure to harmful particles mainly cigarette smoke (CS) (1). WHO projections anticipate
that this chronic and progressive pathology will become the third leading cause of death by 2030.
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In this context, it has become a priority to increase our
research efforts to better understand the cellular and molecular
mechanisms involved in the pathophysiology of pulmonary
inflammation in order to propose new innovative therapies.
A sustained cellular inflammation characterized by airway
neutrophilic recruitment is commonly correlated with
bad prognosis in chronic lung inflammation and COPD
exacerbations elicited by a bacterial or viral infection (2).
Paradoxically, this strong inflammatory response is associated
with impaired bacterial clearance due to ineffective neutrophils
which do not prevent the occurrence of infection-driven
exacerbations (1). Activated neutrophils release reactive oxygen
species as well as pre-formed proteases and lytic enzymes from
intracytoplasmic granules, or burst into neutrophil extracellular
traps (3). However, in addition to proinflammatory effects,
neutrophils can display immunosuppressive potential (4, 5). The
transition between proinflammatory and immunosuppressive
neutrophils is highly dynamic and neutrophil plasticity may
influence immune responses to environmental stress such as CS
exposure (6).
COPD is also characterized by a significant increase in the
number of alveolar macrophages in the airways of patients which
correlates with airway obstruction and COPD severity (7). Both
immune and non-immune cells such as alveolar epithelial cells
participate in the inflammatory cell recruitment consecutive to
CS exposure through their ability to produce chemokines and
cytokines. B cell activating factor (BAFF) belongs to the tumor
necrosis factor (TNF) cytokine family, shown first to play a key
role in the maturation and survival of B lymphocytes and in the
establishment of the humoral response (8, 9). However, recent
data indicate that BAFF may also participate in the regulation
of innate immune responses, particularly at the level of the
respiratory mucosa (10, 11).
BAFF is mainly produced by adaptive immune cells, in
particular B (12, 13) and T (14) lymphocytes as well as
stromal cells especially pulmonary epithelial cells (15). Innate
immune cells such as neutrophils (16), monocytes/macrophages
and dendritic cells can also produce BAFF depending on the
context. BAFF is expressed as a membrane-bound or soluble
protein and its excessive expression leads to the development of
autoimmune disorders in mice and humans (17–19). There are
three BAFF receptors, BAFF receptor (BAFFR), transmembrane
activator and the cyclophilin ligand interactor (TACI), and B
cell maturation antigen (BCMA), all expressed by B and T
lymphocytes but also by antigen presenting cells, indicating that
BAFF function extends beyond that of B cell biology (15).
In addition to its important role in the production of
autoantibodies and in autoimmunity, BAFF is implicated in the
pathophysiology of pulmonary diseases. In particular, we showed
high BAFF levels in the bronchoalveolar lavage fluid of patients
with idiopathic pulmonary fibrosis (10). We also showed that
genetic ablation of BAFF or BAFF neutralization significantly
attenuated pulmonary fibrosis (10). Importantly, B cell BAFF
Abbreviations: CXCL, C-X-C motif chemokine; CS, cigarette smoke; COPD,
chronic obstructive pulmonary disease; BAFF, B cell activating factor; BAL,
bronchoalveolar lavage; BALF, BAL fluid.
expression generates a self-perpetuating loop implicated in
COPD progression by promoting pulmonary B cell survival and
tertiary lymphoid follicles expansion (11, 20–23).
In models of mice chronically exposed to CS, BAFF plays a
major role in the generation of pulmonary antinuclear antibodies
and tertiary lymphoid follicles (11, 23). In addition, BAFFR-Fc
administration significantly attenuated lung inflammation and
alveolar wall destruction (23). However, the role of BAFF in the
development of innate immunity to cigarette smoking has never
been investigated. Here, we report that acute CS exposure in
mice induces BAFF expression in both the bronchoalveolar space
and lungs and revealed neutrophils as the major source of BAFF
during early inflammation. We also show a critical role of BAFF
in acute inflammation to CS. Our results suggest that BAFF is
a crucial mediator in the crosstalk between innate and adaptive
immune responses in the context of CS-induced inflammation
and may provide cues for new therapeutic targets for COPD and
COPD exacerbations.
RESULTS
Acute Cigarette Smoke Exposure
Promotes BAFF Expression in Airway
Recruited Neutrophils
To address the role of BAFF in the development of acute
lung inflammation in response to cigarette smoke (CS),
C57BL/6J wild type mice (WT) were exposed to 4 cigarettes,
three times a day for 4 days and sacrificed 16 h after the
last exposure. WT mice exposed to CS presented significant
increase in the number of total cells recruited into the
bronchoalveolar lavage (BAL) (Figure 1A) and in particular
neutrophils (Figure 1B) and macrophages (Figure 1C), as well
as enhanced myeloperoxidase (MPO) levels (Figure 1D) in BAL
fluid (BALF) which correlates with neutrophil recruitment.
Interestingly, we observed enhanced amounts of BAFF in the
BALF and a trend in the lung homogenates (Figures 1E,F).
Of note we did not observe a significant change in Tnfsf13
mRNA levels (as known as APRIL, another TNF family member;
Figure 1G). BAL cells immunostaining assay employing BAFF
specific antibody indicates that airways recruited neutrophils,
identified by their multi-lobulated nucleus stained with DAPI,
strongly express BAFF in response to CS (Figures 1H,I). At this
time point, BAL macrophages did not seem to express high
levels of BAFF, suggesting that neutrophils are the major source
of BAFF produced in the bronchoalveolar space in response to
acute CS-exposure.
Neutrophil Depletion Partially Decreases
BAFF Expression in Lung of CS-Exposed
Mice
To validate the hypothesis that neutrophils are a major source of
airway secreted BAFF upon mouse CS-exposure, we performed
a neutrophil depletion experiment. Anti-Gr1 antibody (200 µg
per mouse) or its isotype were injected intraperitoneally to
WT mice at days 2 and 4, between the second and the third
CS exposure (Figure 2A). Anti-Gr1 but not isotype control
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FIGURE 1 | Acute CS-exposure induces BAFF expression in airways-recruited neutrophils. Mice were exposed to air (Air) or cigarette smoke (CS) three times a day
for 4 days and sacrificed 16 h after the last exposure. Total cells (A), neutrophils (B), and macrophages (C) counted in BAL. MPO levels in BALF (D). BAFF levels,
respectively, in BALF and lung (E,F). Tnfsf13 mRNA levels (coding for APRIL) in lung homogenates (G). BAFF immunostaining on BAL cells collected after air or CS
exposure: BAFF shown in green and nucleus in blue (DAPI) (H). Fluorescent intensity quantification (I). n = 4–5 mice per group. Bar graphs are expressed as mean ±
SEM. ns, non-significant; *p < 0.05 and **p < 0.01.
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FIGURE 2 | Neutrophil depletion partially decreases pulmonary BAFF levels upon CS-exposure. WT mice were exposed to air or CS. CS-exposed WT mice were
injected intraperitoneally with 200 µg of anti-Gr1 or isotype control antidody per mouse at day 2 and 4 between the second and the third exposure (A). Total cells (B)
and neutrophils (C) counted in BAL. MPO (D,E), CXCL1 (F,G), CXCL5 (H,I), MMP-9 (J,K), and BAFF (L,M) levels were measured in BALF and lung, respectively. n =
4–5 mice per group. Bar graphs are expressed as mean ± SEM. ns, non-significant; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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treated mice display decreased total cell number in BAL
(Figure 2B) and in particular neutrophils (Figure 2C). However,
neutrophil recruitment was not totally abolished indicating that
neutrophil depletion was not complete. We also observed a
significant decrease in MPO levels measured in BALF and
lungs of anti-Gr1 treated mice as compared to isotype control
treated mice (Figures 2D,E). Neutrophil-recruiting chemokines
CXCL1 (Figures 2F,G) and CXCL5 (Figures 2H,I) levels were
significantly increased in the lungs but not in the BALF of CS-
exposed anti-Gr1-treated mice as compared to isotype control-
treatedmice. This increased CXCL1 and CXCL5 lung levels could
be explained by the reduction of recruited neutrophils which
express CXCR2 (the receptor for CXCL1 and CXCL5) and thus
to an increase of unbound chemokines. In contrast, BALF and
lung levels of matrix metalloproteinase-9 (MMP-9), known to
be produced by neutrophils, were strongly decreased in CS-
exposed mice treated within anti-Gr1 antibody (Figures 2J,K).
Importantly BAFF production was significantly induced in BALF
and lungs of CS-exposed isotype control-treated mice but not
in CS-exposed anti-Gr1-treated mice suggesting an important
contribution of neutrophils in BAFF production. However,
we only observed a trend in the decrease of BAFF levels
after anti-Gr1 antibody treatment in comparison to isotype
control treatment (Figures 2L,M), probably due to incomplete
neutrophil depletion or contribution of an additional cellular
source of BAFF.
In vitro CSE Stimulation Induces BAFF
Expression in Neutrophils and Epithelial
Cells
To confirm that neutrophils can secrete BAFF, bone marrow-
derived neutrophils (BMDN) were sorted and stimulated for
4 h with home-made 10% cigarette smoke extract (CSE). We
observed that CSE stimulation significantly increased BAFF
levels in the supernatant of BMDN isolated from WT mice,
indicating that neutrophils are able to secrete BAFF in response
to CSE (Figure 3A). At this time point, 10% CSE did not
promote neutrophil cell death, as observed performing MTT
assay (Figure 3B). Moreover, CSE stimulation of murine tracheal
epithelial cells (MTEC) isolated from WT mice and maintained
immersed in vitro, enhanced intracellular BAFF accumulation as
compared to unstimulated MTEC (Figure 3C). However, BAFF
was undetectable in the supernatant of CSE-stimulated MTEC
suggesting an absence or a finely regulated BAFF secretion
by these cells (data not shown). These results suggest that
neutrophils rather than epithelial cells may be an important
source of airway secreted BAFF in response to CS-exposure.
BAFF Positively Regulates CS-Induced
Airway Inflammation
In order to study the role of BAFF in acute CS-induced lung
inflammation, we exposed wild type (WT) and BAFF deficient
mice (BAFF−/−) to air or CS. While total BAL cell numbers were
not significantly decreased (Figure 4A), neutrophil numbers
and MPO levels in the BAL were significantly decreased
in CS-exposed BAFF−/− mice as compared to WT mice
(Figures 4B,C). Double-stranded (ds) self-DNA level in the
BALF was also reduced in CS-exposed BAFF−/− mice as
compared toWTCS-exposed mice, suggesting lower CS-induced
cell death and/or neutrophil extracellular traps (NETs) formation
in these mice (Figure 4D). In addition, CXCL5 (Figure 4E) and
MMP-9 (Figure 4F) BALF amounts were reduced in CS-exposed
BAFF−/− mice, whereas CXCL1 levels were not (Figure 4G).
We next intranasally administrated recombinant mouse BAFF
(rBAFF) protein (1 µg/mouse) or NaCl at indicated time
points (Figure 4H) and exposed mice to air or CS. CS-exposed
FIGURE 3 | In vitro CSE stimulation induces BAFF expression in neutrophils and epithelial cells. Bone marrow derived neutrophils (BMDN) were stimulated with
medium or medium containing 10% Cigarette Smoke Extrat (CSE) for 4 h. BAFF levels in supernatant (A) and MTT cell viability assay on cellular fraction (B). Murine
tracheal epithelial cells (MTEC) were stimulated with medium or medium containing 10% CSE. BAFF was measured in the cellular fraction (C). Stimulation has been
performed in triplicate for each condition. Bar graphs are expressed as mean ± SEM. ns, non-significant; *p < 0.05. Mann-Whitney T-test was performed.
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FIGURE 4 | BAFF positively controls CS-induced inflammation. WT and BAFF deficient mice (BAFF−/−) were exposed to air or CS and sacrificed 16 h after the last
exposure. WT mice were instillated with NaCl as control, or with rBAFF (1 µg/mouse) at days 2 and 4 between the second and the third exposure (H). Total cells (A,I)
and neutrophils (B,J) in BAL. MPO (C,K), self-dsDNA (D), CXCL5 (E), CXCL1 (G), MMP-9 (F,L), and TIMP-1 (M) levels measured in BALF or lung as indicated.
n = 3–7 mice per group. Bar graphs are expressed as mean ± SEM. ns, non-significant; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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rBAFF-treated mice presented a significant increase in BAL
total cell (Figure 4I) and neutrophils (Figure 4J) in comparison
to NaCl treated CS- or air-exposed mice. Higher neutrophil
pulmonary influx observed in CS-exposed and rBAFF-treated
mice was confirmed by increased BAL MPO levels (Figure 4K)
that were significantly higher as compared to CS-exposed
mice only. Moreover, remodeling factors in the lungs such
as MMP-9 (Figure 4L) and TIMP-1 (Figure 4M) were also
increased in CS-exposed rBAFF-treated mice in comparison to
CS-exposed mice. In conclusion, BAFF deficiency resulted in
decreased pulmonary inflammation to CS-exposure while the
addition of exogenous BAFF to WT mice significantly enhanced
inflammation. Altogether, these data show that BAFF is a key
proinflammatory player during the acute phase of pulmonary
inflammation induced by CS-exposure.
DISCUSSION
Here, we investigated whether BAFF is expressed during the
early stages of cigarette smoke (CS)-induced inflammation
and whether it participated in the development of the early
pulmonary innate immune response. Previous works indicated
that BAFF is strongly expressed in smokers and COPD patients
leading to lymphoid follicles formation and pulmonary B cell
survival (11, 20–23). In chronically CS-exposed mice, BAFF
expression is greatly increased leading to the generation of
pulmonary antinuclear antibodies and tertiary lymphoid tissues
(11, 23). Another study reports that chronic exposure to
cigarette smoke causes decreased airway BAFF levels leading to
enhanced influenza virus infection (24). These discrepancies are
unclear and might reflect the use of distinct mouse colonies
and/or CS exposure protocol. Here we show that acute CS
exposure promotes BAFF expression in the bronchoalveolar
space. Early CS-induced expression of BAFF highlights BAFF
as a crucial mediator in the crosstalk between innate and
adaptive immune responses in the establishment of pulmonary
chronic inflammation.
We previously identified Gr1+ neutrophils as an important
source of BAFF upon BLM-induced lung inflammation and
fibrosis (10). Here, we show in our model that airway neutrophils
are the main BAFF producing cells in the bronchoalveolar space
suggesting that recruited neutrophils are the major source of
BAFF during acute pulmonary inflammation to CS. In contrast,
one study showed that some lung tissue resident alveolar
macrophages express BAFF upon mice acute CS-exposure and
proposed that macrophages are the essential source of pulmonary
BAFF (11). We cannot exclude that macrophages may also
produce BAFF, in particular lung tissue macrophages as observed
by these authors.
Neutrophil depletion experiment confirmed that neutrophils
are important inducers of early pulmonary inflammation.
Neutrophil depletion partially decreases BAFF expression in lung
tissue and bronchoalveolar space of CS-exposed mice suggesting
that while neutrophils are important BAFF producers, additional
sources exist, possibly alveolar macrophages (11) or reflecting
incomplete neutrophil depletion.
Exploring this hypothesis, we showed that murine bone
marrow-derived neutrophils stimulated in vitro with cigarette
smoke extract (CSE) secrete BAFF, confirming that neutrophils
are one of the main source of BAFF. Moreover, epithelial cells
also expressed BAFF after CSE stimulation, but did not secrete
it in this experimental setting. This observation suggests that
epithelial cells could be, in vivo, another source of BAFF during
CS-induced lung inflammation. BAFF-containing epithelial cells
could explain the presence of airway BAFF in air-exposed
mice that do not present airway neutrophils. In addition, a
recent study showed that BAFF production may be induced
in a mouse macrophage cell line by hydrogen peroxide, an
oxidant generated following CS exposure (25). However, in
contrast to bone marrow-derived neutrophils, we did not
observed BAFF production by CSE-stimulated bone marrow-
derived macrophages.
Of note, the use of different exposure models (26), different
mouse strain or sex (25) change the response observed (27).
Proinflammatory mediators were shown to elicit secretion of
the intracellular or surface expressed BAFF during pathologic
inflammatory responses (16, 28). BAFF was associated with
autoimmunity and recent evidence suggests that autoimmune
processes are involved in the pathogenesis of COPD (29). In
this context, neutrophils were shown to produce BAFF and
contribute to excess serum BAFF levels, promoting CD4+ T cell
and B cell responses in autoimmunity model of lupus-prone
mice (30). In addition, prolonged infections or adjuvant usage
can trigger emergency granulopoiesis, leading to dysregulated
neutrophil blood counts. The recruited neutrophils secreted
BAFF that highly accelerated plasma cell generation and antigen-
specific antibody (31).
Importantly, we showed that neutrophil and myeloperoxidase
level reduction in the airways was associated with decreased
airway self-dsDNA content in BAFF deficient mice. These
results indicate that BAFF is necessary for neutrophilic
inflammation and suggest that neutrophils may release self-DNA
through NETs formation which are released during NETosis
cell death. NETs are web-like scaffolds of extracellular DNA
in complex with histones and neutrophil granular proteins,
such as myeloperoxidase and neutrophil elastase. Interestingly,
NETopathic inflammation was recently implicated in the
pathogenesis of COPD (11, 32, 33).
In addition recent studies showed that autoinflammatory
NETs are composed of self-DNA, neutrophil elastase autoantigen
but also BAFF protein, inducing anti-dsDNA antibodies (34, 35).
It will be interesting to analyze whether neutrophil-associated
BAFF release uponCS exposure is occurring through active BAFF
secretion or NETosis. In lungs of patients with COPD, BAFF
expression was increased in immune cells, in particular alveolar
macrophages, but also in stromal cells in lymphoid follicles (20,
23). BAFF expressing cells may differ depending on the chronicity
of inflammation and/or on COPD stage.
Finally, we report a critical role of BAFF in acute inflammation
to CS in mice since genetic ablation of BAFF significantly
attenuated airway neutrophilic inflammation. In the same way,
BAFFR-Fc administration was shown to significantly attenuate
lung inflammation and alveolar wall destruction confirming
Frontiers in Immunology | www.frontiersin.org 7 July 2020 | Volume 11 | Article 1622
Nascimento et al. BAFF in Acute Pulmonary Inflammation
that BAFF has proinflammatory effect (23). Addition of fairly
large amounts of recombinant BAFF to observe whether its
effects are additive to those mediated by CS-induced BAFF
confirms that BAFF positively regulates airway neutrophilic lung
inflammation. It is worth mentioning that 1 µg recombinant
BAFF administration to naïve mice did not lead to significant
differences in terms of BAL cell recruitment and remodeling
factors production. Since neutrophils were not showed to
express BAFF receptors, these results suggest that additional
mediators are required. We previously showed that CS exposure
induces IL-1β production, which is important to promote
neutrophil recruitment as we previously showed (36). Other
demonstrated the role of IL-17 in neutrophil influx in response
to CS exposure (37, 38). One hypothesis is that BAFF may
induces IL-1β and/or IL-17 production in a feedback loop,
leading to neutrophil influx. Since we did not observe an
increase in Tnfsf13 expression, it appears that among the TNF
family, BAFF but not APRIL plays a major role in CS-induced
inflammation. In conclusion, our data demonstrate that innate
immune cells and in particular neutrophils are an important
source of BAFF in early stages of CS-induced lung inflammation
and suggest that BAFF is a crucial mediator in the crosstalk
between innate and adaptive immune responses upon cigarette
smoke exposure.
MATERIALS AND METHODS
Mice
Eight to twelve weeks old wild-type C57BL/6J (WT) male mice
were purchased from the Janvier laboratory (Janvier Laboratory,
France). BAFF−/− (39) were provided by Pascal Schneider
from Lausanne University. All mice were backcrossed 10 times
on C57BL/6J background and housed in the UPS44-TAAM
(CNRS, Orleans, France) animal facility. For experiments, adults
males (8–12 weeks old) were kept in sterile, isolated and
ventilated cages.
Cigarette Smoke Model
CS exposure was performed using a calibrated EMKA InExpose
smoking robot. Mice were exposed to mainstream cigarette
smoke in a whole-body chamber for 20min, 3 times per day for 4
days. We used 3R4F research cigarettes (University of Kentucky)
with the filter removed and the cigarettes were puffed once per
minute, 4 s duration, 200ml puff volume. The experimental bias
flow, required to deliver CS and fresh air to the mice, is calibrated
at 3.107 L.min-1 and maintained constant. We did not measure
the concentration of smoke particulates, but the manufacturer
estimates the exposures to be 350mg/cubic meter.
Treatment
Mice were treated intraperitoneally with 200 µg of mouse
anti-Gr1 (BE0075, Euromedex) or isotype control (BE0090,
Euromedex) at day 2 and 4 between the second and the
third exposition. Recombinant mouse BAFF (8876-BF-010, R&D
Systems) was administred intranasally (1 µg/mouse) at days 2
and 4 of CS exposure between the second and the third daily
exposure. Mice were anesthetized using intramuscular injection
of ketamine/xylasine.
Broncho-Alveolar Lavage (BAL)
BAL was performed as previously described (40).
Bronchoalveolar lavage (BAL) and lung tissue were
harvested 16 h after the last CS exposition. Differential
cell counts were performed by counting an average of
250 cells on Cytospin preparations (Shandon CytoSpin3,
Thermo Scientific) after May-Grünwald-Giemsa (MGG)
staining (Diff Quick, Medion Diagnostics) according to
manufacturer’s instructions.
Lung Homogenates
After BAL the lungs were perfused with Isoton R© (Beckman
Coulter France, Villepinte) to flush the vascular content. Lungs
were homogenized by a rotor-stator (Ultra-turrax R©) in 1ml
of PBS for ELISA dosage. The extract was centrifuged 10min
10,000 rpm and the supernatant was stored at −80◦C before
mediator measurement.
Mediator Measurements
For cytokine determination, BALF supernatant and lung
homogenates or culture supernatant were analyzed by
ELISA assay kits for murine: CXCL1, CXCL5, MPO,
MMP-9, TIMP-1, and BAFF (R&D system) according to
manufacturer’s instructions.
Measurement of Double-Stranded DNA
Double-stranded DNA was measured in the BAL fluid (BALF)
using Quant-iTPicoGreen dsDNA reagent (Invitrogen, Carlsbad,
CA), according to the manufacturer’s protocol.
Quantitative RT-PCR
RNA was purified from lung homogenates by using Tri-Reagent
(Sigma-Aldrich) extraction protocol. Reverse transcription of
RNA into cDNA was carried out with GoScriptTM Reverse
Transcription System (Promega). RT-qPCR was performed with
Fast SYBR Green Master mix (Promega) on anARIAMX(Agilent
Technologies). Primers for Tnfsf13 (#QT00254023) were
purchased from Qiagen (Qiagen, Hilden, Germany). RNA
expression was normalized to Gapdh (#QT00166768) expression
and analyzed using the 11Ct method.
Immunostaining on Cytospin
Cytospin slides were fixed in paraformaldehyde 4% (Sigma-
Aldrich). After 3 lavages in TBS, cells were incubated
10min in TBS-0.3% Triton X-100, were washed 3 times
in TBS, blocked in TBS-1% BSA-10% SVF during 45min
and incubated with primary anti-BAFF (Abcam, ab16081)
or control isotype antibodies over night at 4◦C. After 3
lavages in TBS, cells were incubated 1 h at room temperature
with anti-rat IgM conjugated to Alexa 488. Cytospins
were counterstained using 4
′
,6-diamidino-2-phenylindole
(DAPI) for 10min, rinsed and coverslip were mounted
with Mowiol (Sigma-Aldrich). For fluorescent intensity
quantification, the gray value was calculated in each cell
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selected on untreated pictures. Cells were observed using a
Nikon eclipse 80i microscope and images were treated using
ImageJ software.
Bone Marrow Derived Neutrophils
Femurs from 7 weeks old WT mice were collected and
rapidly flushed in sterile conditions with RPMI/10% FBS and
smashed through a 100µm filter to remove aggregates and
centrifuge at 1,400 rpm for 5min. The pellet was resuspended
in PharmLyse solution (BD Biosciences) to lyse red blood
cells. Lysis reaction was stopped by adding FBS and then
centrifuged 5min at 1,400 rpm. Pellet was resuspended
in PBS-FBS 0.5%-EDTA 2mM buffer prior to isolation.
Neutrophils were isolated using the Neutrophil Isolation
Kit (MiltenyiBiotec) following manufacturer instructions.
Briefly, cells were stained with a cocktail of biotin-conjugated
monoclonal antibodies not expressed on neutrophils. After
that, cells were stained with magnetic anti-biotin antibodies
and separated using magnetic LS Columns (MiltenyiBiotec).
Cells unretained by the colums were numerated and seeded
in a 96 well-plate at 1.105 cells per well prior to stimulation.
Supernatant was collected after 4 h stimulation and stored
at −80◦C for further analysis. Cell death was monitored by
MTT using a standard protocol. Thiazollyl blue tetrazolium
bromide (Sigma) solution was added onto the cells after
supernatant collection and incubated for 2 h at 37◦C, and
a 10% SDS acetic acid solution was then added. MTT
reduction to formazan was quantified by an absorbance
microplate reader (EL800, BioTek, Colmar) at 610 nm
(KC4 software).
Murine Tracheal Epithelial Cells
Trachea fromWTmice were collected in DMEM-F12 GlutaMAX
medium (Thermofisher Scientific) containing Penicillin-
Streptomycin (100 U/mL, Fisher) cocktail and incubated
over night at 4◦C with Pronase (1.5 mg/mL, Sigma-Aldrich).
Cells were collected and washed 3 times with DMEM-F12
GlutaMAX-10% FBS, 100µm filtered, and centrifuged at
1,500 rpm for 10min. Cell pellet was resuspended in DNAse
solution (0.5 mg/mL, Sigma-Aldrich) for 5min. Suspension
was centrifuged for 10min at 1,500 rpm and the pellet
was resuspended in DMEM-F12 GlutaMAX media and
incubated in Primaria plates (353801, VWR) at 37◦C for
4 h to remove potential fibroblasts. Unadherent cells were
then collected, centrifuged at 1,500 rpm for 10min, counted
and plated in 24 well-plate coated with rat tail collagen
(ThermoFisher Scientific) at 50 000 cells per well. At this
step, DMEM-F12 GlutaMAX-5% FBS medium containing
Insulin-Transferrin (10µM ThermoFisher Scientific), Cholera
Toxin (0.10µg/mL, Sigma-Aldrich) Epidermal Growth Factor
(0.025µg/mL, Sigma-Aldrich), Bovine Pituitary Extract
(30µg/mL, Fisher), and Retinoic acid (50 nM, Sigma-Aldrich)
was used to maintain epithelial cells prior to stimulation.
Supernatant and intracellular fraction were stored at −80◦C for
further analysis.
In vitro Cell Stimulation
Cigarette Smoke Extract was prepared by bubbling the
smoke of six 3R4F cigarettes with filter per 100mL of
media. This solution is considered as 100% CSE medium
stock solution.
Statistical Analysis
Statistical evaluation of differences between experimental groups
was determined by Mann Whitney T-Test or one-way ANOVA,
analysis of variance, Bonferroni test as indicated using GraphPad
Prism software v.8. P <0.05 were considered statistically
significant. All figures are representative of at least two
different experiments.
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